《“PLOD2是宫颈癌中一种有效的预后标志物并与免疫浸润相关”的勘误》
Corrigendum to "PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer".
作者信息
Li Guang, Liu Guobing, Wang Xuefeng
机构信息
Department of Obstetrics and Gynecology, Third Affiliated Hospital of Southern Medical University, Guangzhou, 510515 Guangdong Province, China.
Department of Obstetrics and Gynecology, NanFang Hospital of Southern Medical University, Guangzhou, 510515 Guangdong Province, China.
出版信息
Biomed Res Int. 2021 Oct 23;2021:9762405. doi: 10.1155/2021/9762405. eCollection 2021.
Abstract
[This corrects the article DOI: 10.1155/2021/5512340.].
摘要
[本文更正了文章的数字对象标识符：10.1155/2021/5512340。]
相似文献
1
Corrigendum to "PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer".《“PLOD2是宫颈癌中一种有效的预后标志物并与免疫浸润相关”的勘误》
Biomed Res Int. 2021 Oct 23;2021:9762405. doi: 10.1155/2021/9762405. eCollection 2021.
2
PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.PLOD2是一种有效的预后标志物，与宫颈癌中的免疫浸润相关。
Biomed Res Int. 2021 Jun 28;2021:5512340. doi: 10.1155/2021/5512340. eCollection 2021.
3
Corrigendum: A Weighted Gene Co-Expression Network Analysis-Derived Prognostic Model for Predicting Prognosis and Immune Infiltration in Gastric Cancer.勘误：一种基于加权基因共表达网络分析的预测胃癌预后和免疫浸润的预后模型。
Front Oncol. 2021 Apr 14;11:683333. doi: 10.3389/fonc.2021.683333. eCollection 2021.
4
Corrigendum: A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer.勘误：基于免疫相关长链非编码RNA的宫颈癌患者预后模型
Front Pharmacol. 2021 Aug 25;12. doi: 10.3389/fphar.2021.723153. eCollection 2021.
5
Hypoxia and TGF-β1 induced PLOD2 expression improve the migration and invasion of cervical cancer cells by promoting epithelial-to-mesenchymal transition (EMT) and focal adhesion formation.缺氧和转化生长因子-β1诱导的PLOD2表达通过促进上皮-间质转化（EMT）和粘着斑形成来改善宫颈癌细胞的迁移和侵袭。
Cancer Cell Int. 2017 May 12;17:54. doi: 10.1186/s12935-017-0420-z. eCollection 2017.
6
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.勘误：NPM1是一种参与肺腺癌免疫浸润、与m6A修饰和糖酵解相关的预后生物标志物。
Front Immunol. 2021 Aug 31;12:751004. doi: 10.3389/fimmu.2021.751004. eCollection 2021.
7
Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.勘误：CDT1是一种用于肝细胞癌的新型预后和预测生物标志物。
Front Oncol. 2021 Nov 9;11:801970. doi: 10.3389/fonc.2021.801970. eCollection 2021.
8
PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics.PLOD2 通过促进癌症干细胞样特征促进喉癌的耐药性。
BMC Cancer. 2019 Aug 27;19(1):840. doi: 10.1186/s12885-019-6029-y.
9
PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection.缺氧诱导的 PLOD2 是肝细胞癌根治性切除术后的一个新的预后因素。
Liver Int. 2012 Jan;32(1):110-8. doi: 10.1111/j.1478-3231.2011.02619.x. Epub 2011 Aug 11.
10
Corrigendum: Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer.勘误：环氧化酶-2和β-连环蛋白作为子宫内膜癌潜在的诊断和预后标志物
Front Oncol. 2020 Nov 3;10:582704. doi: 10.3389/fonc.2020.582704. eCollection 2020.
引用本文的文献
1
A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.基于癌症干性和代谢相关基因的宫颈癌和宫颈内膜腺癌新型预后标志物。
Aging (Albany NY). 2024 Apr 23;16(8):7293-7310. doi: 10.18632/aging.205757.
2
A Fe-dependent self-inhibited state influences the druggability of human collagen lysyl hydroxylase (LH/PLOD) enzymes.铁依赖性自我抑制状态影响人类胶原蛋白赖氨酸羟化酶（LH/PLOD）的可成药性。
Front Mol Biosci. 2022 Aug 25;9:876352. doi: 10.3389/fmolb.2022.876352. eCollection 2022.
本文引用的文献
1
PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.PLOD2是一种有效的预后标志物，与宫颈癌中的免疫浸润相关。
Biomed Res Int. 2021 Jun 28;2021:5512340. doi: 10.1155/2021/5512340. eCollection 2021.
Zotero 插件